Detalhe da pesquisa
1.
Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia.
Blood
; 121(8): 1296-303, 2013 Feb 21.
Artigo
Inglês
| MEDLINE | ID: mdl-23287861
2.
Extramedullary Waldenström macroglobulinemia.
Am J Hematol
; 90(2): 100-4, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25349134
3.
Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study.
Lancet Oncol
; 12(3): 263-72, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21345726
4.
The role of 18F-FDG PET/CT imaging in Waldenstrom macroglobulinemia.
Am J Hematol
; 86(7): 567-72, 2011 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-21681781
5.
Renin-Angiotensin-Aldosterone System Blockers Prior to Hospitalization and Their Association With Clinical Outcomes in Coronavirus Disease 2019 (COVID-19).
Cureus
; 13(2): e13429, 2021 Feb 18.
Artigo
Inglês
| MEDLINE | ID: mdl-33758716
6.
Prevalence of hepatopancreatic injury and clinical outcomes in patients with COVID-19 in USA.
Int J Emerg Med
; 14(1): 68, 2021 Nov 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34742236
7.
Convalescent Plasma in COVID-19.
HCA Healthc J Med
; 1(3): 139-146, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-37424714
8.
Editor's Note: Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia.
Clin Cancer Res
; 30(4): 919, 2024 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38362728
9.
Mechanisms of activity of the TORC1 inhibitor everolimus in Waldenstrom macroglobulinemia.
Clin Cancer Res
; 18(24): 6609-22, 2012 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23048077
10.
The role of serum immunoglobulin free light chain in response and progression in waldenstrom macroglobulinemia.
Clin Cancer Res
; 17(9): 3013-8, 2011 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21415221